BioPharmGuy logo
Sponsored By:
Project Management Now
Purchase the BioPharmGuy data
Sinclair Research
Tularik is defunct.

Fate: Bought by Amgen, March 2004, $1.3B


------------------
If you believe any of this information is incorrect, please let us know.